Targeted Cannabinoid Medicines for Women’s Health and Metabolic Disease
Our approach
Precision designed cannabinoid compounds produced through synthetic chemistry, delivering pharmaceutical-grade consistency without the complexity, cost, or variability of plant-derived extraction. Our team has decades of cannabinoid pharmacology experience and we apply it to precisely defined clinical targets where the endocannabinoid system plays a validated role.
Our Focus
We build targeted cannabinoid therapies for complex therapeutic areas, including menopause and metabolic health. Our plant-inspired, modern chemistry approach delivers rationally designed compounds with the consistency, purity, and regulatory clarity that patients, physicians and payers require.
The Science
Pionarus compounds are designed from established cannabinoid science, not discovered through botanical screening. Our synthetically enabled, plant-informed approach allows us to optimize for target selectivity, oral bioavailability, and tissue-specific activity from day one — across a portfolio of cannabinoid compounds.